BRL 20330, an oral prodrug of temocillin: bioavailability studies in man. 1986

M J Basker, and D J Merrikin, and R J Ponsford, and B Slocombe, and T C Tasker

BRL 20330 is the o-methyl phenyl ester of temocillin which is well absorbed after oral administration and converted to temocillin in the body. BRL 20330 was administered to healthy subjects in a three-part cross-over study with single doses equivalent to 400, 600 and 800 mg of temocillin. Peak serum concentrations of temocillin were 9.8, 12.8 and 15.8 mg/l respectively and concentrations of 3.0-6.0 mg/l were measured at 12 h after dosing. High and prolonged concentrations of temocillin were measured in the urine. The mean urinary recovery was 22-25% and only 0.2% of unhydrolyzed BRL 20330 was detected in the urine. Little difference in the extent of absorption was noted when BRL 20330 was administered with food although the peak levels of temocillin were delayed and reduced slightly. Urinary concentrations of temocillin, even after 24 h, were bactericidal for a number of Gram-negative bacteria including multi-resistant strains. BRL 20330 was well tolerated and there was no evidence of gastro-intestinal adverse effects.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D005502 Food Substances taken in by the body to provide nourishment. Foods
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

M J Basker, and D J Merrikin, and R J Ponsford, and B Slocombe, and T C Tasker
January 1983, Infection,
M J Basker, and D J Merrikin, and R J Ponsford, and B Slocombe, and T C Tasker
October 1989, Journal of pharmaceutical sciences,
M J Basker, and D J Merrikin, and R J Ponsford, and B Slocombe, and T C Tasker
March 1985, The Journal of antimicrobial chemotherapy,
M J Basker, and D J Merrikin, and R J Ponsford, and B Slocombe, and T C Tasker
February 1984, European journal of clinical microbiology,
M J Basker, and D J Merrikin, and R J Ponsford, and B Slocombe, and T C Tasker
May 1982, The Journal of antimicrobial chemotherapy,
M J Basker, and D J Merrikin, and R J Ponsford, and B Slocombe, and T C Tasker
April 1983, The Journal of antimicrobial chemotherapy,
M J Basker, and D J Merrikin, and R J Ponsford, and B Slocombe, and T C Tasker
April 1982, Antimicrobial agents and chemotherapy,
M J Basker, and D J Merrikin, and R J Ponsford, and B Slocombe, and T C Tasker
October 1989, Antimicrobial agents and chemotherapy,
M J Basker, and D J Merrikin, and R J Ponsford, and B Slocombe, and T C Tasker
September 1997, Advanced drug delivery reviews,
M J Basker, and D J Merrikin, and R J Ponsford, and B Slocombe, and T C Tasker
October 1986, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!